Vietnam Airlines, Vietjet, and Sun PhuQuoc Airways Sign Major Boeing Aircraft Deals Amid U.S.–Vietnam Trade Talks 
Airbus Cuts Jet Production Target Amid Pratt & Whitney Engine Shortages, Q4 Profit Jumps 17% 
Waymo Clarifies Role of Remote Workers Amid U.S. Robotaxi Safety Scrutiny 
Microsoft Plans $50 Billion AI Investment to Accelerate Growth in the Global South 
Freedom Finance and Binance Join Forces in Digital Assets 
Federal Court Fines Mobil Oil Australia A$16 Million for Misleading Fuel Claims 
Boeing Secures 50 737 MAX Jet Order from Vietnam Airlines Amid Expanding Global Demand 
Bill Gates Pulls Out of India’s AI Impact Summit Amid Controversy and Event Mismanagement 
Qualcomm to Invest $150 Million in India AI Startups, Strengthening Presence in Growing Market 
Thomas Pritzker to Step Down as Hyatt Executive Chairman After Epstein Ties Acknowledged 
AstroTurf Expands Footprint at Colorado as Buffaloes Complete Second Installation in 12 Months 
Luxury Stocks Face Volatility as AI Market Swings and Hedge Fund Bets Rattle LVMH and Kering 
OpenAI Nears $100 Billion Funding Round at $850 Billion Valuation: Bloomberg Report 
Hedge Funds Cut Nvidia, Amazon and Microsoft Stakes as AI Valuation Concerns Rise 
BETHLEHEM, Pa., May 03, 2018 -- B. Braun Medical Inc., an industry pioneer in offering products not made with DEHP and PVC, will showcase its portfolio of solution containers at the CleanMed 2018 Conference & Exposition on May 7-9 at the Sheraton San Diego Hotel and Marina in booth #203.
Di-ethylhexyl Phthalate (DEHP) and Polyvinyl Chloride (PVC) are potentially toxic to patients and the environment – and they’re commonly used in IV bags, tubing, and packaging.
“B. Braun has been at the forefront of recognizing the patient and environmental risk posed by exposure to products containing DEHP and PVC. We were one of the first IV fluid manufacturers to remove these toxic substances from many of our products and proudly remain the only supplier that offers a full-line of IV solution containers that are not made with DEHP and PVC,” said Tom Sutton, Vice President of Marketing, Medical Device and Pharmaceutical Systems.
Over the past seven years, B. Braun has invested more than $750 million in developing increased capacity, and innovative ways to offer environmentally friendly IV solutions. This includes new product lines not made with DEHP, PVC, or natural rubber latex. B. Braun actively supports policies calling for the industry-wide reduction of these chemicals and natural rubber latex in medical devices.
For more information on these products, call B. Braun Clinical and Technical Support at 800-854-6851. For more information on DEHP and PVC in healthcare, visit www.BBraunCares.com.
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. Other key product areas include ostomy and wound care, dialysis, nutrition, pharmacy admixture and compounding. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than 61,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com.
Contact: Jason Ford
B. Braun Medical Inc.
610.997.4722
[email protected]
